---
document_datetime: 2026-01-21 14:36:59
document_pages: 6
document_pathfilename: www.ema.europa.eu/en/documents/procedural-steps-after/humalog-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf
document_name: humalog-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf
version: success
processing_time: 20.7531595
conversion_datetime: 2026-02-01 20:19:20.817004
docling_version:
  docling-serve: 1.11.0
  docling-jobkit: 1.9.1
  docling: 2.71.0
  docling-core: 2.62.0
  docling-ibm-models: 3.11.0
  docling-parse: 4.7.3
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
## Humalog

Procedural steps taken and scientific information after the authorisation*

*Due to the Agency' s update of its procedure management systems, an additional document, reflecting the historical lifecycle may be available in the 'Assessmenthistory'section.Forthe completeproduct lifecycleprocedures,you mayneedtoalsorefertoEPAR-Proceduralsteps taken andscientific information after authorisation (archive).

| Applicationnumber    | Scope                              | Opinion/ Notification 1 issued on   | Commission Decision IssuedÂ²/ amendedon   | Product Information affected3   | Summary   |
|----------------------|------------------------------------|-------------------------------------|------------------------------------------|---------------------------------|-----------|
| Variation typeIA_IN/ | A.ADMINISTRATIVECHANGES-A.1 Change | 21/01/2026                          |                                          | SmPC,                           |           |

<!-- image -->

<!-- image -->

<div style=\"page-break-after: always\"></div>

| EMA/VR/0000315488   | in the name and/or address of the marketing authorisation holder - Accepted                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |            |     | Labelling and PL   |                   |
|---------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|--------------------|-------------------|
| Variation type IA / | B.II.d.2 Change in test procedure for the finishedproduct-B.II.d.2.bDeletion of a testprocedureifanalternativemethodis already authorised - Accepted B.II.d.2 Change in test procedure for the finishedproduct-B.II.d.2.eUpdate of the test procedure to comply with the updated general monograph in the Ph. Eur. - Accepted B.II.b.5 Change to in-process tests or limits applied during the manufacture of the finished product - B.II.b.5.a Tightening of in- process limits - Accepted B.II.d.2 Change in test procedure for the finished product-B.II.d.2.bDeletion of a testprocedure if an alternativemethod is alreadyauthorised-Accepted B.II.d.2Changeintestprocedurefor the finishedproduct-B.II.d.2.fToreflect compliancewith thePh.Eur.andremove referencetotheoutdatedinternaltest method and testmethodnumber-Accepted B.II.d.2 Change in test procedure for the | 09/10/2025 | N/A |                    | EMA/VR/0000302558 |

<div style=\"page-break-after: always\"></div>

|                                     | test procedure to comply with the updated general monograph in the Ph. Eur. - Accepted B.II.d.1 Change in the specification parameters and/or limits of the finished product - B.II.d.1.c Addition of a new specification parameter to the specification with its corresponding testmethod- Accepted                                                                                                                                                                                                                                                                                                                          |            |     |
|-------------------------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|
| Variation typeIB/ EMA/VR/0000281212 | This was an applicationfor a group of variations following a worksharing procedure accordingtoArticle20ofCommission Regulation(EC)No1234/2008. B.I.a.2 Changes in the manufacturing process of the active substance - B.I.a.2.a Minor change in themanufacturingprocess of theactive substance-Accepted B.I.a.2 Changes in the manufacturing process of the active substance - B.I.a.2.a Minor change in the manufacturing process of theactivesubstance-Accepted B.I.a.2 Changes in the manufacturing process of the active substance - B.I.a.2.a Minor change in the manufacturing process of the active substance-Accepted | 04/09/2025 | N/A |

<div style=\"page-break-after: always\"></div>

| Variation type IB / EMA/VR/0000278799   | Thiswas an applicationfor a group of variations. B.I1.b.5 Change to in-process tests or limits applied during the manufacture of the finished product-B.II.b.5.z Other changes- Accepted B.II.b.5 Change to in-process tests or limits applied during the manufacture of the finished product-B.II.b.5.z Other changes- Accepted B.11.b.5Change toin-process tests orlimits applied during the manufacture of the finished product-B.II.b.5.zOther changes- Accepted B.I1.b.4 Change in the batch size (including batch sizeranges)of thefinishedproduct- B.II.b.4.f The scale for a biological/immunological medicinal product isincreased/decreasedwithoutprocess change (e.g. duplication of line) - Accepted   | 15/07/2025   | N/A   |
|-----------------------------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|-------|
| VariationtypeIB/ EMA/VR/0000262180      | Thiswas an applicationfor avariation following a worksharing procedure according toArticle 20 of Commission Regulation(EC) No 1234/2008. B.II.b.1 Replacement or addition of a                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     | 22/05/2025   | N/A   |

<div style=\"page-break-after: always\"></div>

|                                       | manufacturing siteforpartor all of the manufacturing process of the finished product - B.1I1.b.1.a Secondary packaging site-Accepted                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |            |     |
|---------------------------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|
| Variation type IB / EMA/VR/0000253644 | This was an application for a group of variations following a worksharing procedure accordingtoArticle20ofCommission Regulation(EC)No 1234/2008. B.11.b.5 Change toin-processtests orlimits applied during the manufacture of the finished product-B.II.b.5.z Other changes- Accepted B.I1.b.5 Change to in-process tests or limits applied during the manufacture of the finished product - B.I1.b.5.z Other changes - Accepted B.II.b.5 Change to in-process tests or limits applied during the manufacture of the finished product-B.II.b.5.z Other changes- Accepted B.I1.b.4 Change in the batch size (including batch size ranges) of the finished product - B.II.b.4.f The scale for a biological/immunological medicinalproduct is increased / decreased without process | 25/04/2025 | N/A |

<div style=\"page-break-after: always\"></div>